Trials / Sponsors / TrueBinding, Inc.
TrueBinding, Inc.
Industry · 7 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A Phase 2a Multicenter Clinical Trial of TB006 in Participants With Parkinson's Disease Parkinson's Disease (PD) | Phase 2 | 2025-03-20 |
| Terminated | A Long Term Extension Study to Assess the Safety of TB006 in Participants With Alzheimer's Disease Alzheimer's Disease | Phase 2 | 2022-09-14 |
| Withdrawn | A Study to Assess the Efficacy, Safety, and Pharmacokinetics of TB006 in Participants With Acute Ischemic Stro Acute Ischemic Stroke | Phase 2 | 2022-07-26 |
| Completed | Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of TB006 in Partici Alzheimer's Disease | Phase 1 / Phase 2 | 2021-10-08 |
| Completed | Sequential Dose-escalation Study to Assess the Safety, Tolerability and Pharmacokinetics of TB006 in Healthy S Alzheimer Disease | Phase 1 | 2021-06-01 |
| Withdrawn | Study of TB006 in Outpatient Patients With Mild to Moderate COVID-19 Covid19 | Phase 1 | 2021-06-01 |
| Available | TB006 Expanded Access (EA) Compassionate Use Alzheimer Disease | — | — |